News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss     7/25/2016
Merck & Co. (MRK) Nabs Breakthrough Tag for Ebola Zaire Vaccine From the FDA and PRIME Status From EMA     7/25/2016
Vtesse Bags Another $17 Million to Support Further Product Development and Expand Ongoing Clinical Trials     7/25/2016
Why Investors Should Pay Attention to Seattle Genetics (SGEN)' Drug Trial     7/21/2016
Juno (JUNO) Stock Falls Again After Correcting Number of Trial Deaths     7/18/2016
Juno (JUNO) Soars After the FDA OKs Restart of Clinical Trial     7/14/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study     7/14/2016
3 Nauseating Clinical Trial Flops of 2016 So Far     7/12/2016
Juno (JUNO) Halts CAR-T Cancer Trial After Three Patient Deaths     7/11/2016
Sucampo (SCMP) Terminates Development of Cobiprostone Following Phase II Data     7/11/2016
AbbVie (ABBV)'s $175 Million Gamble Pays Off as Ablynx (ABLYF) RA Drug Meets Goal in Phase II Study     7/8/2016
Pfizer (PFE) Stock Climbs With Positive Renal Cancer Phase III Data     7/8/2016
This Year’s Top 10 Disappointing Clinical Trials—So Far!     7/6/2016
Shire (SHPG)'s Retinopathy Treatment Fails to Meet Primary Endpoint in Phase II     7/1/2016
Infinity Pharma (INFI) Cuts Jobs by 58% as AbbVie (ABBV) Terminates Duvelisib Collaboration Deal     6/30/2016

Featured Stories
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN)     7/11/2016
ASCO2016: What's Next For Cancer-Killing T-Cells After Strong ASCO Showings     6/8/2016
Down's Syndrome 'Can Be Treated With Green Tea,' Centre for Genomic Regulation Study     6/7/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
Can-Fite BioPharma (CFBI) Completes Phase II Study Design For CF102 In The Treatment Of NASH/NAFLD     7/25/2016
Eiger Biopharma Announces First Patient Dosed In Phase 2 ULTRA Study Of Ubenimex In Secondary Lymphedema     7/25/2016
PTC Therapeutics (PTCT) Provides Regulatory Update On Translarna (Ataluren)     7/25/2016
Tobira (TBRA) To Host Conference Call At 8:30 A.M. Eastern Time Tomorrow To Discuss CENTAUR Phase 2b Trial Results     7/25/2016
ViaCyte Awarded New CIRM Grant To Develop PEC-Direct For High-Risk Type 1 Diabetes     7/22/2016
Diversity Of Eli Lilly (LLY)'s Alzheimer's Disease Pipeline Showcased At The Alzheimer's Association International Conference 2016 (AAIC 2016)     7/21/2016
DNAtrix, Inc. Announces Successful Intratumoral Delivery Of DNX-2401 Via Alcyone's MEMS Cannula For The Targeted Treatment Of Recurrent Glioblastoma     7/21/2016
Advaxis (ADXS)’ AXAL Receives Fast Track Designation By The FDA As Adjuvant Therapy For High-Risk Locally Advanced Cervical Cancer Patients     7/21/2016
Rhythm Announces The New England Journal of Medicine Publication Of Setmelanotide Phase 2 Data For Treatment Of POMC Deficiency Obesity     7/21/2016
Novan Announces First Patient Dosed In Phase 2 Anti-Fungal Program     7/21/2016
CytoDyn (CYDY) Submits Orphan Drug Application To FDA For Pretreatment With PRO 140 Of Treatment-Naïve HIV Patients     7/21/2016
BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely To The Skin     7/21/2016
Hansa Medical Interim Report April – June 2016     7/21/2016
Eiger Biopharma Announces Completion Of Dosing In Phase 2 LOWR HDV - 3 Study At NIH     7/20/2016
Cell Medica Release: Lead Cancer Immunotherapy Candidate Granted EU Orphan Drug Designations     7/20/2016

More News
No News Posted on that date

Career Tips
The ROI of Gratitude: Two Biotechs Getting It Right     7/18/2016
Top 14 Life Science Jobs in California     7/14/2016
Top 5 Bay Area Biomed Hot Spots     6/30/2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer     6/16/2016
What’s at the Heart of Alnylam (ALNY)'s Company Culture?     6/3/2016
Jobs Outlook for the Life Science Class of 2016     6/2/2016
Top 20 Entry-Level Life Science Jobs in Massachusetts     5/19/2016
Eli Lilly (LLY) and Regeneron (REGN) Tips: How to Find Your First Biopharma Job Right Out of College     5/19/2016
Life Science Ranks Among Top 9 College Majors to Get a Job     5/5/2016
10 Best U.S. States for Working Moms     5/5/2016
The Highest Paying Life Sciences Jobs     4/21/2016
4 Things New Life Science Graduates Need to Know to Land that First Job     4/21/2016
Talent Connect Draws Scores of Life Science Companies in Massachusetts     4/13/2016
The 5 Best Life Science Companies with Great Perks and Work Culture     4/8/2016
Dealing with Rejection During the Job Search     4/7/2016

Other News Sources
//-->